Marjorie R. Levinstein

957 total citations
17 papers, 566 citations indexed

About

Marjorie R. Levinstein is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Marjorie R. Levinstein has authored 17 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Marjorie R. Levinstein's work include Neurotransmitter Receptor Influence on Behavior (8 papers), Neuropeptides and Animal Physiology (6 papers) and Tryptophan and brain disorders (5 papers). Marjorie R. Levinstein is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (8 papers), Neuropeptides and Animal Physiology (6 papers) and Tryptophan and brain disorders (5 papers). Marjorie R. Levinstein collaborates with scholars based in United States, Spain and France. Marjorie R. Levinstein's co-authors include Benjamin A. Samuels, René Hen, Zoe R. Donaldson, Cornelius T. Gross, Noelia Madroñal, Theodoros Tsetsenis, Kenji F. Tanaka, Liam Drew, Christoph Anacker and Alex Dranovsky and has published in prestigious journals such as Nature Communications, Neuron and Nature Neuroscience.

In The Last Decade

Marjorie R. Levinstein

17 papers receiving 565 citations

Peers

Countries citing papers authored by Marjorie R. Levinstein

Since Specialization

Citations

This map shows the geographic impact of Marjorie R. Levinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjorie R. Levinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjorie R. Levinstein more than expected).

Fields of papers citing papers by Marjorie R. Levinstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjorie R. Levinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjorie R. Levinstein. The network helps show where Marjorie R. Levinstein may publish in the future.

Co-authorship network of co-authors of Marjorie R. Levinstein

This figure shows the co-authorship network connecting the top 25 collaborators of Marjorie R. Levinstein. A scholar is included among the top collaborators of Marjorie R. Levinstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjorie R. Levinstein. Marjorie R. Levinstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Locomotor activity depends on β-arrestin recruitment by the dopamine D1 receptor in the striatal D1-D3 receptor heteromer 2025 ·Pharmacological Research ·Andrew R. Evans, (unknown), William Rea, (unknown), Marjorie R. Levinstein, Alessandro Bonifazi, Jianjing Cao, Shelley N. Jackson, Lei Shi, (unknown), (unknown), Vicent Casadó, Christopher J. Earley, Amy Hauck Newman, Michael Michaelides, Leonardo Pardo, Estefanía Moreno, Sergi Ferré	1
2	Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions? 2025 ·American Journal of Psychiatry ·Marjorie R. Levinstein, (unknown), Jordi Bonaventura, Alan F. Schatzberg, Carlos A. Zarate, Michel Michaelides	13
3	Sex dependence of opioid-mediated responses to subanesthetic ketamine in rats 2024 ·Nature Communications ·Tommaso Di Ianni, (unknown), Marjorie R. Levinstein, (unknown), (unknown), Michael Michaelides, Raag D. Airan	19
4	Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone 2023 ·Molecular Psychiatry ·Marjorie R. Levinstein, Paulo Alexandre de Oliveira, (unknown), César Quiroz, (unknown), Rana Rais, William Rea, (unknown), (unknown), Verònica Casadó-Anguera, Estefanía Moreno, Donna Walther, Grant C. Glatfelter, David Weinshenker, Carlos A. Zarate, Vicent Casadó, Michael H. Baumann, Leonardo Pardo, Sergi Ferré, Michael Michaelides	7
5	Exploring the role of mu opioid receptors in the therapeutic potential and abuse liability of (S)-ketamine 2023 ·Neuropsychopharmacology ·Marjorie R. Levinstein, Michael Michaelides	3
6	In vivo photopharmacology with light-activated opioid drugs 2023 ·Neuron ·(unknown), Xiang Ma, (unknown), Caroline A. Johnson, (unknown), (unknown), Susan T. Lubejko, (unknown), (unknown), Jingjing Zhou, (unknown), (unknown), (unknown), Marjorie R. Levinstein, Juan L. Gomez, Jordi Bonaventura, Michael Michaelides, Matthew R. Banghart	20
7	6-O-(2-[18F]Fluoroethyl)-6-O-Desmethyl-Diprenorphine ([18F]FE-DPN) Preferentially Binds to Mu Opioid Receptors In Vivo 2022 ·Molecular Imaging and Biology ·Marjorie R. Levinstein, (unknown), Juan L. Gomez, (unknown), (unknown), Gjermund Henriksen, Daniel P. Holt, Robert F. Dannals, Martin G. Pomper, Carlos A. Zarate, Jordi Bonaventura, Michael Michaelides	8
8	Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability 2022 ·Biological Psychiatry ·Marjorie R. Levinstein, (unknown), Tommaso Di Ianni, (unknown), (unknown), Juan L. Gomez, (unknown), Yavin Shaham, Raag D. Airan, Carlos A. Zarate, Jordi Bonaventura, Michael Michaelides	33
9	PACAP‐expressing neurons in the lateral habenula diminish negative emotional valence 2022 ·Genes Brain & Behavior ·Marjorie R. Levinstein, (unknown), (unknown), (unknown), Koichi Hashikawa, Garret D. Stuber, John F. Neumaier	11
10	Dentate gyrus activin signaling mediates the antidepressant response 2021 ·Translational Psychiatry ·Mark M. Gergues, Christine N. Yohn, (unknown), Marjorie R. Levinstein, Benjamin A. Samuels	16
11	Stress induces divergent gene expression among lateral habenula efferent pathways 2020 ·Neurobiology of Stress ·Marjorie R. Levinstein, Kevin R. Coffey, (unknown), Atom J. Lesiak, John F. Neumaier	7
12	5-HT_1B Receptor-Mediated Activation of ERK1/2 Requires Both Gα_i/o and β-Arrestin Proteins 2019 ·ACS Chemical Neuroscience ·Yusha Liu, (unknown), Marjorie R. Levinstein, Atom J. Lesiak, Shao‐En Ong, John F. Neumaier	9
13	The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor 2017 ·Neuropsychopharmacology ·Benjamin A. Samuels, Katherine M. Nautiyal, Andrew C. Kruegel, Marjorie R. Levinstein, Valerie Magalong, Madalee M. Gassaway, Steven G. Grinnell, (unknown), Michael Ansonoff, John E. Pintar, Jonathan A. Javitch, Dalibor Sameš, René Hen	83
14	S 38093, a histamine H3 antagonist/inverse agonist, promotes hippocampal neurogenesis and improves context discrimination task in aged mice 2017 ·Scientific Reports ·Jean‐Philippe Guilloux, Benjamin A. Samuels, Indira Mendez‐David, (unknown), Marjorie R. Levinstein, Charlène Faye, (unknown), Elisabeth Mocaër, Alain M. Gardier, René Hen, (unknown), Denis J. David	24
15	Role of adult hippocampal neurogenesis in persistent pain 2015 ·Pain ·A. Vania Apkarian, Amelia Mutso, Maria Virginia Centeno, Lixin Kan, Melody V. Wu, Marjorie R. Levinstein, Ghazal Banisadr, Kevin T. Gobeske, Richard J. Miller, Jelena Radulović, René Hen, John A. Kessler	95
16	5-HT1A receptors on mature dentate gyrus granule cells are critical for the antidepressant response 2015 ·Nature Neuroscience ·Benjamin A. Samuels, Christoph Anacker, (unknown), Marjorie R. Levinstein, (unknown), Theodoros Tsetsenis, Noelia Madroñal, Zoe R. Donaldson, Liam Drew, Alex Dranovsky, Cornelius T. Gross, Kenji F. Tanaka, René Hen	149
17	Mechanisms underlying the antidepressant response and treatment resistance 2014 ·Frontiers in Behavioral Neuroscience ·Marjorie R. Levinstein, Benjamin A. Samuels	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact